← Who reports today · Health Care
DVA · Q2 2026
Archived report (Q2 2026). Latest deep dive →
The quarter in brief
Revenue grew 5.2% y/y to $3.55B, operating margin 16.3% vs 15.9%, net income $265M (+33.1% y/y).
Net income attributable to DaVita Inc.
$265M
up 33.1% y/y
Total revenues
$3,554M
up 5.2% y/y
Operating income
$579M
up 7.7% y/y
All figures in $M.
| Line item | Amount and change |
|---|---|
| Dialysis patient service revenues | $3,366 · +5.0% |
| Other revenues | $188 · +8.7% |
| Total revenues | $3,554 · +5.2% |
| Patient care costs | $2,392 · +5.8% |
| General and administrative | $423 · +2.6% |
| Depreciation and amortization | $168 · −3.9% |
| Equity investment income, net | $8.2 · +11.1% |
| Operating income | $579 · +7.7% · 16.3% margin |
| Debt expense | $150 · +2.9% |
| Debt extinguishment and modification costs | $2 · vs $0 |
| Other income (loss), net | $8.3 · vs −$22.9 |
| Income before income taxes | $435 · +17.9% |
| Income tax expense | $91.8 · −2.0% · 21.1% effective rate |
| Less: Net income attributable to noncontrolling interests | $77.8 · +2.6% |
| Net income attributable to DaVita Inc. | $265 · +33.1% · $4.02/sh · 7.5% margin |
Verdict: revenue grew 5.2% y/y to $3.55B, operating margin 16.3% vs 15.9%, net income $265M (+33.1% y/y).
Source and notation
Source: DaVita press release, 8-K EX-99.1 of 08/04/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.
Open as an image: DVA, Q2 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “DVA Q2 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/dva/q2-2026. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/dva/q2-2026"><img src="https://whoreportstoday.com/t/dva/q2-2026/sankey.png" alt="DVA Q2 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/dva/q2-2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/dva/q2-2026/sankey.png
<a href="https://whoreportstoday.com/t/dva/q2-2026">DVA Q2 2026 earnings chart (Who Reports Today)</a>
This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- Operating income was $579M, a 16.3% margin vs 15.9% a year earlier.
- The effective tax rate was 21.1% vs 25.4% a year earlier.
- Diluted EPS was $4.02 vs $2.58 a year earlier.
What distorts the picture in this report and what to watch beyond the headlines.
DVA — a kidney care provider that runs outpatient dialysis centers, provides dialysis in hospitals and at home, and offers integrated kidney care.
Its one reportable segment is U.S. dialysis and related lab services; integrated kidney care, other ancillary services and operations outside the U.S. are reported together as other segments. · Source: annual report (Form 10-K, SEC)
More reports: DXCM · Q3 2026 · ELV · Q3 2026 · EW · Q2 2026 · GEHC · Q3 2026 · GILD · Q3 2026 · HCA · Q3 2026 · HSIC · Q2 2026 · HUM · Q2 2026 · IDXX · Q2 2026 · ILMN · Q3 2026 · all reports